Abstract 1611 Neonatology: Clinical Investigation Platform, Monday, 5/3
Early onset Group B Streptococcus (EOGBS) disease, defined by an onset within the first 72 hours of life, occurs in 1-4 per 1000 live births.
Objectives: To determine the impact of the new CDC/AAP/ACOG guidelines on prepartum screening, intrapartum management, incidence of EOGBS infection, and course of neonates born to GBS colonized women at University MacDonald Women's Hospital in Cleveland, Ohio from 1/1/95 to 12/31/97.
Methods: A retrospective analysis by chart review of mothers and infants <72 hrs, comparing women identified as GBS colonized: Period I - women who delivered 1/1/95 to 6/30/96 [prior to institutional implementation of the guidelines for management of GBS colonization], and Period II - women who delivered 7/1/96 to 12/31/97 after implementation of the guidelines.
Results: (Table)
Conclusions: In complying with the new screening and treatment guidelines there was a significant increase in the number of mothers screened and the detection of maternal colonization, plus a 63% reduction in EOGBS. There was also a substantial reduction in the number of invasive procedures on the neonates. We conclude that the new guidelines are both medically and economically effective.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Share, L., Roworth, S., Jacobs, M. et al. Cost Effectiveness of Implementation of Guidelines for Preventing Early Onset Group B Streptococcal Infection [EOGBS]. Pediatr Res 45, 274 (1999). https://doi.org/10.1203/00006450-199904020-01628
Issue Date:
DOI: https://doi.org/10.1203/00006450-199904020-01628